Kato Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development of novel therapies
for pathologies of the eye with an emphasis on unmet medical needs.

Biotechnology

Kato Pharmaceuticals

Kato Pharmaceuticals' headquarters in Laguna Hills, CA, United States

Terrance Mcgovern

Andrew Wade

Kenneth Mandell

Charles Wyckoff

Arshad Khanani

Roger Goldberg

Thomas Hohman

Stephen Montgomery

Angela Kothe

Alan Weiner

Olav Bergheim

James Bernstein

The Clinical and Regulatory Advising Team at Kato Pharmaceuticals ensures that the company's novel therapies for ocular diseases meet all clinical and regulatory standards. This team provides strategic guidance on clinical trial design, navigates complex regulatory landscapes, and ensures compliance with quality and manufacturing standards to facilitate the timely approval and market introduction of new treatments.

Clinical and Regulatory Advising Team

The Leadership Team at Kato Pharmaceuticals is responsible for setting the strategic direction of the company, overseeing financial operations, and driving the development of innovative therapies for eye pathologies. Comprising the CFO and Co-founders, they work collaboratively to secure funding, manage resources efficiently, and ensure alignment with the company’s mission to address unmet medical needs in ophthalmic care.

Leadership Team

Kato Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical and Regulatory Advising Team

Leadership Team

Offices

Kato Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical and Regulatory Advising Team

Leadership Team

Offices

Related companies